Skip to Main Content

Paper Details

The utility of real-world evidence for benefit-risk assessment, communication, and evaluation of pharmaceuticals: Case studies.
Pharmacoepidemiol Drug Saf
8
2020
Author NameAffiliation
Paul M Coplan
Paul M CoplanPerelman School of Medicine, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
  • 1 - 2

Datasets

Release 1.2